Zota Health Care [ZOTA] vs 3B Blackbio [3BBLACKBIO] Detailed Stock Comparison
Zota Health Care
NSE
Loading...
3B Blackbio
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Zota Health Care wins in 6 metrics, 3B Blackbio wins in 12 metrics, with 0 ties. 3B Blackbio appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zota Health Care | 3B Blackbio | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -61.40 | 25.06 | Zota Health Care |
| Price-to-Book Ratio | 35.51 | 4.79 | 3B Blackbio |
| Debt-to-Equity Ratio | 0.61 | 0.11 | 3B Blackbio |
| PEG Ratio | -24.56 | 1.91 | Zota Health Care |
| EV/EBITDA | -933.01 | 23.83 | Zota Health Care |
| Profit Margin (TTM) | -20.55% | 49.51% | 3B Blackbio |
| Operating Margin (TTM) | -10.35% | 51.98% | 3B Blackbio |
| EBITDA Margin (TTM) | N/A | 51.98% | N/A |
| Return on Equity | -38.38% | 17.58% | 3B Blackbio |
| Return on Assets (TTM) | -12.84% | 16.11% | 3B Blackbio |
| Free Cash Flow (TTM) | $-959.42M | $424.53M | 3B Blackbio |
| Dividend Yield | 0.11% | N/A | N/A |
| 1-Year Return | 87.10% | 2.74% | Zota Health Care |
| Price-to-Sales Ratio (TTM) | 13.38 | 12.42 | 3B Blackbio |
| Enterprise Value | $34.19B | $12.16B | Zota Health Care |
| EV/Revenue Ratio | 11.67 | 12.25 | Zota Health Care |
| Gross Profit Margin (TTM) | 56.43% | 75.00% | 3B Blackbio |
| Revenue per Share (TTM) | $92 | $116 | 3B Blackbio |
| Earnings per Share (Diluted) | $-20.82 | $57.31 | 3B Blackbio |
| Beta (Stock Volatility) | 0.45 | 0.28 | 3B Blackbio |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zota Health Care vs 3B Blackbio Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zota Health Care | -2.67% | -9.12% | 2.79% | 23.33% | 45.25% | 54.94% |
| 3B Blackbio | 1.64% | -11.51% | -1.70% | -25.19% | -20.50% | -27.08% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zota Health Care | 87.10% | 365.15% | 725.42% | 1,261.32% | 1,261.32% | 1,261.32% |
| 3B Blackbio | 2.74% | 80.63% | 80.63% | 80.63% | 80.63% | 80.63% |
Performance & Financial Health Analysis: Zota Health Care vs 3B Blackbio
| Metric | ZOTA | 3BBLACKBIO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹32.82B | ₹12.33B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 126,671 | 11,965 |
| 90 Day Avg. Volume | 90,885 | 8,132 |
| Last Close | ₹1,204.30 | ₹1,436.75 |
| 52 Week Range | ₹535.00 - ₹1,397.30 | ₹1,253.80 - ₹2,350.00 |
| % from 52W High | -13.81% | -38.86% |
| All-Time High | ₹1,397.30 (Aug 18, 2025) | ₹2,350.00 (Dec 09, 2024) |
| % from All-Time High | -13.81% | -38.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.84% | 0.14% |
| Quarterly Earnings Growth | 0.84% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.21% | 0.50% |
| Operating Margin (TTM) | -0.10% | 0.52% |
| Return on Equity (TTM) | -0.38% | 0.18% |
| Debt to Equity (MRQ) | 0.61 | 0.11 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹35.76 | ₹299.81 |
| Cash per Share (MRQ) | N/A | ₹14.62 |
| Operating Cash Flow (TTM) | ₹-1,007,999,000 | ₹619.97M |
| Levered Free Cash Flow (TTM) | ₹-563,984,000 | ₹476.52M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.11% | N/A |
| Last 12-Month Dividend | ₹1.00 | N/A |
Valuation & Enterprise Metrics Analysis: Zota Health Care vs 3B Blackbio
| Metric | ZOTA | 3BBLACKBIO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -61.40 | 25.06 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -24.56 | 1.91 |
| Price to Sales (TTM) | 13.38 | 12.42 |
| Price to Book (MRQ) | 35.51 | 4.79 |
| Market Capitalization | ||
| Market Capitalization | ₹32.82B | ₹12.33B |
| Enterprise Value | ₹34.19B | ₹12.16B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.67 | 12.25 |
| Enterprise to EBITDA | -933.01 | 23.83 |
| Risk & Other Metrics | ||
| Beta | 0.45 | 0.28 |
| Book Value per Share (MRQ) | ₹35.76 | ₹299.81 |
Financial Statements Comparison: Zota Health Care vs 3B Blackbio
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZOTA | 3BBLACKBIO |
|---|---|---|
| Revenue/Sales | ₹1.04B | ₹222.35M |
| Cost of Goods Sold | ₹451.33M | ₹55.60M |
| Gross Profit | ₹584.50M | ₹166.75M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-107.17M | ₹115.57M |
| EBITDA | ₹48.28M | ₹161.51M |
| Pre-Tax Income | ₹-130.85M | ₹158.64M |
| Income Tax | ₹6.93M | ₹32.19M |
| Net Income (Profit) | ₹-137.78M | ₹126.45M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZOTA | 3BBLACKBIO |
|---|---|---|
| Cash & Equivalents | ₹21.32M | ₹124.73M |
| Total Current Assets | ₹1.84B | ₹1.32B |
| Total Current Liabilities | ₹1.01B | ₹185.88M |
| Long-Term Debt | ₹1.08B | ₹3.07M |
| Total Shareholders Equity | ₹2.27B | ₹2.71B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹1.81B | ₹72.19M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZOTA | 3BBLACKBIO |
|---|---|---|
| Operating Cash Flow | ₹-8.57M | N/A |
| Capital Expenditures | ₹-982,011 | N/A |
| Free Cash Flow | ₹41.94M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ZOTA | 3BBLACKBIO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 126,671 | 11,965 |
| Average Daily Volume (90 Day) | 90,885 | 8,132 |
| Shares Outstanding | 25.85M | 8.58M |
| Float Shares | 12.58M | 2.62M |
| % Held by Insiders | 0.00% | 0.65% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Zota Health Care vs 3B Blackbio
| Metric | ZOTA | 3BBLACKBIO |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | N/A |
| Last 12-Month Dividend Yield | 0.11% | N/A |
| 3-Year Avg Annual Dividend | ₹1.17 | N/A |
| 3-Year Avg Dividend Yield | 0.30% | N/A |
| 3-Year Total Dividends | ₹3.50 | N/A |
| Ex-Dividend Date | Sep 20, 2024 | N/A |